Drug Target Review – Issue 3 2019
Posted: 10 September 2019 | Drug Target Review | No comments yet
This issue includes an investigation into utilising recombinant antibodies for research, a highlight on protein design using computational methods and an examination of the advances in genomic medicine. Also in the issue are articles on next generation sequencing and upstream bioprocessing.


Included in this issue:
- ANTIBODIES
 Evaluation of therapeutic antibody discovery technologies
 Nancy Lopez-Anton, Antibody Discovery Group, Oxford Genetics
- FLOW CYTOMETRY
 Training and development in flow cytometry and other core technologies
 Derek Davies, The Francis Crick Institute
- GENOMICS
 The elegant parallel of using CRISPR to understand disease mechanisms
 Dr Mark Behlke, Integrated DNA Technologies (IDT)
- UPSTREAM BIOPROCESSING
 Spotlighting data in upstream bioprocesses – a recipe for quick and successful cell lines
 Unjulie Bhanot, IDBS
- CNS/NEUROSCIENCE
 Slowing progression in Parkinson’s
 Dr Heather Mortiboys, University of Sheffield’s Institute for Translational Neuroscience (SITraN)
The rest of this content is restricted - login or subscribe free to access


Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Analytical Techniques, Antibodies, Central Nervous System (CNS), Clinical Trials, Disease Research, Drug Delivery, Drug Development, Drug Targets, Flow Cytometry, Gene Therapy, Genome Editing, Genomics, Hit-to-Lead, Imaging, Neurosciences, Next-Generation Sequencing (NGS), Research & Development, Sequencing







